Source Capital Recapitalizes CTL Amedica

May 1, 2021

Source Capital, through its Source Capital Credit Opportunities Fund III (SCCO III), provided debt financing to recapitalize and supply growth funding for CTL Amedica, a designer, manufacturer and distributor of spinal fusion and fixation products. The financing will support CTL Amedica's product-portfolio expansion—including its silicon nitride spinal implants—and ongoing commercialization to surgeons and healthcare providers across the U.S.

Targets
CTL Amedica
Industry
Medical Devices
Location
Texas, United States
Transaction Type
Recapitalization

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.